Pretreatment of CFs with colivelin TFA markedly enhanced hyperglycemia-induced YY1 nuclear translocation, cell proliferation and activation, and ECM protein up-regulation, while DAPA did not reverse these effects. The gene discussed is YY1; the disease is Hyperglycemia.